Giuliani E R, Zaki F G, Hall J C
Toxicol Pathol. 1983;11(1):23-7. doi: 10.1177/019262338301100104.
Comparative studies of enzyme activities during the dedifferentiation of hepatic cells and through their development into overt hepatomas are few and contradictory. This study was designed to investigate the histochemical, biochemical and morphologic features of the altered liver cells with particular emphasis on the importance and validity of the histoenzymatic behavior of glucose-6-phosphatase (G6Pase) as a marker for the detection of precancerous hepatic cells. Serum and hepatic levels of G6Pase were analyzed and compared with the histoenzymatic behavior of this enzyme. The use of other enzymes, such as adenosine triphosphatase (ATPase) and gamma glutamyl-transpeptidase (GGT) as histochemical markers for malignancy was also tested. The activities of a variety of enzymes commonly used as diagnostic tools were also evaluated in both the liver homogenates and sera of rats treated with 2 mg diethylnitrosamine (DENA)/kg body weight for 2-28 weeks. Using G6Pase as a histoenzymatic marker, precancerous cells appeared after 4 weeks of exposure to DENA in the form of small islets devoid of G6Pase activity. These G6Pase free cells increased in number forming larger islands and finally appeared as tumor nodules after 28 weeks of treatment. The histoenzymatic behavior of ATPase was identical to that of G6Pase. The precancerous cells, as well as the tumor cells appeared devoid of ATPase activity. The application of GGT as a marker, showed significantly increased activity in the altered liver and tumor cells. Increased serum levels of G6Pase were noted after 10 weeks and were greatly elevated in the late stages of the evolution of the precancerous cells.(ABSTRACT TRUNCATED AT 250 WORDS)
肝细胞去分化过程及其发展为明显肝癌过程中酶活性的比较研究较少且相互矛盾。本研究旨在调查肝细胞改变的组织化学、生物化学和形态学特征,特别强调葡萄糖-6-磷酸酶(G6Pase)的组织酶行为作为检测癌前肝细胞标志物的重要性和有效性。分析并比较了G6Pase的血清和肝脏水平及其组织酶行为。还测试了其他酶,如腺苷三磷酸酶(ATPase)和γ-谷氨酰转肽酶(GGT)作为恶性肿瘤组织化学标志物的应用。对用2毫克/千克体重二乙基亚硝胺(DENA)处理2至28周的大鼠的肝脏匀浆和血清中常用作诊断工具的多种酶的活性也进行了评估。以G6Pase作为组织酶标志物,暴露于DENA 4周后出现无G6Pase活性的小胰岛形式的癌前细胞。这些无G6Pase的细胞数量增加,形成更大的岛,在处理28周后最终呈现为肿瘤结节。ATPase的组织酶行为与G6Pase相同。癌前细胞以及肿瘤细胞均无ATPase活性。GGT作为标志物的应用显示,在改变的肝脏和肿瘤细胞中活性显著增加。10周后血清G6Pase水平升高,在癌前细胞演变后期大幅升高。(摘要截断于250字)